An experimental AI-created drug for an incurable lung disease had a surprising effect during trials: it made the body's biological age indicators drop by 6 years, towards a younger state.

An experimental drug called Rentosertib, created by biotech company Insilico Medicine using artificial intelligence, has shown an unexpected effect. It was developed against an incurable lung disease, but during the tests, the indicators by which scientists estimate the biological age of the body changed in patients.